Is SBRT better than surgery in older patients with localized lung cancer? Limited general adverse events… and what if we add CGA?? Waiting for results from LIVE LUNG study! @StefanJeppesen#SIOG2023#DCCCAge#gerionc
Elevated pre-treatment NLR and PLR are not associated with poorer overall survival in patients with NSCLC treated with SBRT.
Stop by poster P-241 to hear more @SIOGorg@MeliaHotelsInt Valencia
#SIOG2023@onko_ouh
Big data is promising for studying outcome in older adults as presented by @SPilleron. But importantly: large ≠ good. Bias still occurs in large databases so having a methodologist on board is essential in my opinion.
Utilizing multidisciplinary team strenghs, starts with defining individual roles and strengths! Great points by Dr. Valentin Goede. An important take away message from this years @SIOGorg#SIOG2022
Thromboembolism is a common and potentially life-threatning complication in older patient with cancer. Good prophylactic treatment exist, but identifying patients who might benefit from prophylaxis remains a challenge! Hear more at @SIOGorg poster no. 29 🫁🩸👨🏼⚕️ #SIOG2022
Head of Department of Oncology @OUHhospital@StefanJeppesen giving an update on radiotherapy at @SIOGorg#SIOG2022. Radiotherapy - an effective treatment modality with limited toxicity in older patients with cancer. @onko_ouh
Great presentations at AgeCare day, representing ongoing research @AgeCare1. Proud to be in the company of these sharp research minds from multiple departments working together through AgeCare @OUHhospital to increase our understanding of issues relevant to older pts with cancer.
Forskning i fokus i eftermiddag på Onkologisk Afdeling @OUHhospital - spændende præsentationer fra hele afdelingen med nye forskningsresultater fra bl.a @AgeCare1 #MRLinac#COVID19dk#PRECODE#brystkræft @PRO_ON_Dk og #G8 👍🏼